During the past decade, Advanced Neurosciences Research, LLC conducted 18 clinical trials. In the 10-year time frame, 18 clinical trials started and 16 clinical trials were completed, i.e. on average, 88.9% percent of trials that started reached the finish line to date. In the past 5 years, 8 clinical trials started and 6 clinical trials were completed. i.e. 75% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Advanced Neurosciences Research, LLC" #1 sponsor was "Hoffmann-La Roche" with 6 trials, followed by "Allergan" with 5 trials sponsored, "Genentech, Inc." with 3 trials sponsored, "JANSSEN Alzheimer Immunotherapy Research & Development, LLC" with 3 trials sponsored and "EMD Serono Research & Development Institute, Inc." with 3 trials sponsored. Other sponsors include 7 different institutions and companies that sponsored additional 14 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Advanced Neurosciences Research, LLC" #1 collaborator was "Pfizer" with 4 trials as a collaborator, "Bayer" with 2 trials as a collaborator, "Merck KGaA, Darmstadt, Germany" with 2 trials as a collaborator, "Mallinckrodt ARD Inc." with 1 trials as a collaborator and "Roche Pharma AG" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "Advanced Neurosciences Research, LLC" are "Multiple Sclerosis" (7 trials), "Multiple Sclerosis, Relapsing-Remitting" (7 trials), "Alzheimer's Disease" (3 trials), "Migraine, With or Without Aura" (3 trials) and "Cervical Dystonia" (2 trials). Many other conditions were trialed in "Advanced Neurosciences Research, LLC" in a lesser frequency.

Most popular intervention types in "Advanced Neurosciences Research, LLC" are "Drug" (26 trials), "Biological" (5 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Ocrelizumab" (8 trials), "Placebo" (7 trials), "Interferon beta-1a" (3 trials), "Antihistamine" (2 trials) and "Atogepant" (2 trials). Other intervention names were less common.

The vast majority of trials in "Advanced Neurosciences Research, LLC" are 31 trials for "All" genders.

Currently, there are NaN active trials in "Advanced Neurosciences Research, LLC". undefined are not yet recruiting, 5 are recruiting, 5 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 17 completed trials in Advanced Neurosciences Research, LLC, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Advanced Neurosciences Research, LLC, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 23 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 0 trials that are defined as “Not Applicable".